Europe’s biotech sector is under intense pressure – from capital scarcity and investor caution to fierce global competition and rising expectations for technical and operational excellence.
But with pressure comes opportunity. This event brings together leading experts in biotech, venture capital, partnering, and investment to reveal how European biotech companies can build the capabilities, capital plans, and investor confidence needed to scale globally in 2026 and beyond.
Key Themes
The New Realities of European Biotech
- A market split into two: mega-funds vs. flat rounds
- Why VCs are tightening focus on near – and clinical-stage assets
- How capability gaps limit biotech growth – and how to fix them
Winning in a Hyper-Competitive Licensing Environment
- How to position assets for global pharma partners
- What BD teams and strategic buyers look for in 2026
- Why Europe has unique opportunities – and unique disadvantages
Attracting Capital in a Cautious Funding Climate
- “Flat is the new up”: what it really means for fundraising
- Building investor-ready plans that emphasise:
✓ capital efficiency
✓ stepwise milestones
✓ early human validation
✓ fast-fail experiments for de-risking - Understanding how mega-funds evaluate European opportunities
- Preparing for longer timelines and tougher diligence
Building the Next Generation of European Biotech Leaders
- Operational and leadership capabilities required for global success
- The role of team quality, governance, and investor-requested management upgrades
- How to elevate European biotech onto the global stage
Featured Speakers
Thought leaders from venture capital, corporate finance, healthcare investment, and biotech strategy,
sharing real-world insights on how to:
- Position your biotech company for partnering success
- Craft a compelling investor narrative – beyond “great science”
- Navigate Europe’s fragmented capital landscape
- Build capabilities for sustainable growth
Who Should Attend
- Biotech founders and CEOs
- R&D, BD, and commercial strategy leaders
- Venture capital & private equity professionals
- Pharma innovation & partnering executives
- Industry analysts and ecosystem builders
Date: Tuesday, 27 January 2026
Time: 8:30 – 11:00
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark – Hub 2
Program
| 8:30 | Networking, registration and light breakfast |
| 9:00 | Welcome and introduction to Medicon Valley Alliance David Munis Zepernick, Director, Member Engagement & Communication, Medicon Valley Alliance |
| 9:05 | European biotech on the global stage Max Baumann, Partner, Treehill Partners |
| 9:35 | How to attract funding in Europe’s cautious biotech market: strategies for the next round Anna Gran, Principal, Sound Bioventures |
| 10:10 | Audience Q&A |
| 10:30 | Networking |
| 11:00 | End of Good Morning Meeting |
Speakers
 |
Max Baumann, Partner, Treehill Partners He has a background in corporate finance and healthcare investment banking from UBS and Blackstone prior to co-founding Treehill in 2014. Transacted >$40 billion in deal value across transaction structures, development stages, therapeutic areas, geographies, and market cycles. Next to transaction biopharma companies and their assets, helped build, evolve and rebuild biopharma companies from preclinical to tail-end stage. Masters degrees in business and medicine. |
 |
Anna Gran, Principal, Soundventures Before joining Sound Bioventures, Anna worked in pharmaceutical business development and external innovation at Novo Nordisk and Johnson & Johnson Innovation, where she spent 10 years in innovation scouting, dealmaking, post-merger integration, and strategic alliances. Anna also has prior experience from drug launch management, commercial operations, and medical affairs at Johnson & Johnson; and she spent nearly a decade in biomedical research in institutions in Finland and the Netherlands. She holds an MBA from Cambridge University, Judge Business School, a PhD in biochemistry focusing on cancer and inflammation, and an MSc from the University of Helsinki. She is based in Copenhagen, Denmark. |
| Organized by | In collaboration with |
 |
 |